List of Patents Acquired and Currently Being Acquired

“Diabetes Cure” and “Biozipcode Technology (Cell Targeting Technology)” have been internationally patented.

These technologies enable a fundamental treatment of diabetes, significantly improving the lives of patients. BioZipCode Technology allows for targeting specific cells, maximizing therapeutic efficacy while minimizing side effects. These innovative treatments provide new hope to diabetes patients and open up new possibilities in the medical field.

International Application Number：PCT/JP2020/039044
Date of Application：16.10.2020
Inventors：KOJIMA Hideto, TERASHIMA Tomoya, KATAGI Miwako
Title of the Invention：Diabetes Therapy Targeting Abnormal Stem Cells
Applicant：Biozipcode, Inc.
https://patentscope.wipo.int/search/ja/detail.jsf?docId=WO2021075535

International Application Number：PCT/JP2020/039045
Date of Application：16.10.2020
Inventors：KOJIMA Hideto, TERASHIMA Tomoya, KATAGI Miwako
Title of the Invention：Therapy for Diabetes Using Stem Cell Migration Agent
Applicant：Biozipcode, Inc.
https://patentscope.wipo.int/search/ja/detail.jsf?docId=WO2021075536

International Application Number：PCT/JP2022/008036
Date of Application：25.02.2022
Inventors：KOJIMA Hideto, TERASHIMA Tomoya, KATAGI Miwako
Title of the Invention：Therapy For Diabetes Using Stem Cell Migration Agent
Applicant：Biozipcode, Inc.（Transferred from Shiga University of Medical Science）
https://patentscope2.wipo.int/search/ja/detail.jsf?docId=WO2021075536

International Application Number：PCT/JP2022/008036
Date of Application：25.02.2022
Inventors：KOJIMA Hideto, KATAGI Miwako
Title of the Invention：Method or Agent with HDAC Regulator, for Treatment of Diabetes and Complications
Applicant：Biozipcode, Inc.（Transferred from Shiga University of Medical Science）
https://patentscope2.wipo.int/search/ja/detail.jsf?docId=WO2021075536